COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 188 filers reported holding COHERUS BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,090 | -12.4% | 3,500 | 0.0% | 0.00% | – |
Q2 2023 | $14,945 | -37.6% | 3,500 | 0.0% | 0.00% | – |
Q1 2023 | $23,940 | -13.6% | 3,500 | 0.0% | 0.00% | – |
Q4 2022 | $27,720 | -16.0% | 3,500 | 0.0% | 0.00% | – |
Q3 2022 | $33,000 | +32.0% | 3,500 | 0.0% | 0.00% | – |
Q2 2022 | $25,000 | -44.4% | 3,500 | 0.0% | 0.00% | – |
Q1 2022 | $45,000 | -18.2% | 3,500 | 0.0% | 0.00% | – |
Q4 2021 | $55,000 | -1.8% | 3,500 | 0.0% | 0.00% | – |
Q3 2021 | $56,000 | +16.7% | 3,500 | 0.0% | 0.00% | – |
Q2 2021 | $48,000 | -5.9% | 3,500 | 0.0% | 0.00% | – |
Q1 2021 | $51,000 | -15.0% | 3,500 | 0.0% | 0.00% | – |
Q4 2020 | $60,000 | -6.2% | 3,500 | 0.0% | 0.00% | – |
Q3 2020 | $64,000 | +3.2% | 3,500 | 0.0% | 0.00% | – |
Q2 2020 | $62,000 | +10.7% | 3,500 | 0.0% | 0.00% | – |
Q1 2020 | $56,000 | -11.1% | 3,500 | 0.0% | 0.00% | – |
Q4 2019 | $63,000 | -10.0% | 3,500 | 0.0% | 0.00% | – |
Q3 2019 | $70,000 | -30.0% | 3,500 | -30.0% | 0.00% | -100.0% |
Q3 2015 | $100,000 | – | 5,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |